CI vs NUS · P/E 2.4, rev $274.90B vs P/E 4.9, rev $1.73B
Cigna Corp (CI) versus Nu Skin Enterprises Inc (NUS) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Nu Skin Enterprises Inc (NUS) is a household & personal products company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported NUS revenue for 2024-12-31 was $1.73B. Net income was -$146.6M. Revenue was down 12.0% from 2023-12-31 to 2024-12-31. NUS currently screens at market cap $258.3M and trailing P/E 4.9.
CI currently screens at market cap $71.62B and trailing P/E 2.4. NUS currently screens at market cap $258.3M and trailing P/E 4.9.
Not investment advice. Open the CI and NUS stock pages for the full models.
Not investment advice.